Superadmin CRO Prodia, Author at Prodia The CRO

Frost & Sullivan Recognizes Prodia the CRO as 2025 Indonesian Clinical Research Organization Company of the Year.

Posted on February 10, 2026February 11, 2026 by Superadmin CRO Prodia

As a pioneer of local Clinical Research Organization (CRO) in Indonesia, PT Prodia Diacro Laboratories (Prodia CRO) has once again been honored by Frost & Sullivan as the Company of the Year 2025 for best practices in the Indonesian clinical research organization industry [See the full list of Company of the Year 2025 winners by Frost & Sullivan]. This achievement marks eight consecutive years of longstanding recognition from Frost & Sullivan, which began with the Best Indonesia CRO awards in 2014 and 2015, followed by the Indonesia CRO Customer Value Leadership Awards in 2020 and 2021, and the Company of the Year Awards in 2022, 2023, 2024, and 2025.

“As Indonesia emerges as a regional clinical research hub, PT Prodia Diacro Laboratories stands at the forefront—combining international standards with deep local expertise to unlock the country’s full research potential. Through integrated services, CAP-accredited laboratories, and a pioneering site management model, Prodia is not only bridging global sponsors with Indonesia’s diverse patient population but shaping the future of clinical trials across Southeast Asia.”
— Unmesh Lal, Vice President, Healthcare & Life Sciences, Frost & Sullivan.

Frost & Sullivan’s evaluation reflects how Prodia CRO continues to bridge Indonesia’s potential with global research excellence. Through international-standard–based and wide-ranging integrated clinical trial services, a wide network of CAP-accredited laboratories supported by its sister company, Prodia Widyahusada, and a scalable site management model, Prodia strengthens site readiness and investigator capability across Indonesia.

Frost & Sullivan also recognized Prodia CRO’s commitment to operational excellence, strategic foresight, and ecosystem development, which enable the company to deliver consistent, high-quality clinical trial solutions for both local and global clients, advancing Indonesia’s role as an emerging hub for global clinical research. [Discover more about Prodia the CRO’s Company of the Year Award].

Watch the highlight video of Prodia CRO’s recognition by Frost & Sullivan below.

Prodia CRO Participates in the Workshop on Basic Clinical Trial Implementation at Fatmawati Central General Hospital

Posted on December 1, 2025December 1, 2025 by Superadmin CRO Prodia

On 27 November 2025, the Clinical Research Unit (CRU) of Fatmawati Central General Hospital hosted the Workshop on Basic Clinical Trial Implementation to Foster a Research Culture in Hospitals. The workshop aimed to strengthen hospital capacity in conducting standardized, ethical, and sustainable clinical trials while fostering a culture of research across healthcare institutions.

Prodia CRO contributed to this event through Dr. apt. Ida Paulina Sormin, M.Si., our Site Management Organization (SMO) Manager, served as one of the speakers with the topic “Clinical Trial Implementation and Hospital Procedures.” This participation reflects Prodia CRO’s ongoing commitment to supporting the development of Indonesia’s clinical research ecosystem.

In addition to Prodia CRO and IASMED, the workshop featured speakers from various institutions who presented topics essential for advancing clinical trial readiness and governance in hospitals, including:

dr. Dona Arlinda, M.Sc. (Ministry of Health / INA CRC)
Ministry of Health Guidance on the Implementation of Clinical Trials in Vertical Hospitals
Yuyus Kusnadi, PhD (IASMED)
Clinical Trial Process Flow
Rima Haifa, S.Si., M.Farm-Klin (ProSTEM)
Advancing Clinical Evidence: ProSTEM’s Current and Emerging Research-Based Stem Cell Therapies
Dr. dr. Utami Purbasari, Sp.Rad(K)
Clinical Trial Workflow at Fatmawati Central General Hospital
dr. Muhammad Ikhsan Mokoagow, Sp.PD, KEMD, M.Med, Sci, FINASIM
Clinical Trial Progress Updates at Fatmawati

The workshop was held in a hybrid format, attended by onsite participants from Fatmawati Hospital and online participants from vertical hospitals across Indonesia. The strong engagement demonstrated a shared commitment to enhancing institutional readiness and improving the quality of clinical trials nationwide.

Prodia CRO is proud to support initiatives that strengthen clinical research capacity and remains dedicated to contributing to high-quality, ethical, and impactful clinical trial conduct in Indonesia.

Prodia CRO Participates in Soetomo Research Hub 2025 “Build Hospital Reputation through Research” – Dr. Soetomo General Hospital Surabaya, October 27, 2025

Posted on November 5, 2025November 5, 2025 by Superadmin CRO Prodia

Prodia The CRO took part in the Soetomo Research Hub 2025 organized by Dr. Soetomo General Hospital, themed “Build Hospital Reputation through Research.” The event brought together key stakeholders in clinical research, including representatives from hospitals, academia, regulators, Contract Research Organizations (CROs), and sponsors across Indonesia.

Representing Prodia The CRO, Dr. Ida Paulina, MSi., Apt, Site Management Organization Manager, was invited as one of the speakers and delivered a session on “Insurance for Clinical Trials.” The presentation highlighted the importance of ensuring subject protection and risk management as part of ethical and high-quality clinical trial governance.

Beyond the presentations, Prodia CRO also joined the Networking Session with other CROs, research institutions, universities, and sponsors — fostering stronger collaboration and knowledge exchange within Indonesia’s clinical research ecosystem.

Prodia CRO’s active involvement reflects its ongoing commitment to advancing clinical research standards and supporting hospitals and academic institutions in strengthening research capacity nationwide.

Highlights from Singapore DIA 2025 and Asia DIA 2025

Posted on July 21, 2025October 20, 2025 by Superadmin CRO Prodia

Prodia had the opportunity to attend the Singapore Drug Information Association (DIA) 2025 and Asia DIA 2025 conferences. Held in Singapore, these events brought together industry professionals, researchers, and regulatory experts to share knowledge and insights on the latest developments in drug development, clinical trials, and regulatory affairs.

The conferences featured a range of sessions, including keynote presentations, panel discussions, and workshops, covering topics such as innovative trial designs, real-world evidence, and regulatory updates. Prodia team had the chance to engage with speakers and attendees, learning about the latest trends and best practices in the industry.

Attending these conferences provided valuable opportunities for networking, professional development, and staying up-to-date on the latest industry developments.

Prodia the CRO was attending The 2025 APAC Health and Life Science Summit – Spotlight Indonesia which took place on June 3, 2025

Posted on June 5, 2025October 20, 2025 by Superadmin CRO Prodia

Prodia the CRO was attending The 2025 APAC Health and Life Science Summit – Spotlight Indonesia which took place on June 3, 2025, at the prestigious Westin Hotel, marking a significant milestone as the first time ASK Health Asia organized this esteemed event in Indonesia. This summit served as a pivotal platform, bringing together industry leaders, policymakers, and innovators to explore Indonesia’s evolving policy landscape, regional regulatory and innovation partnerships, investment opportunities, and local collaboration models.

The event was inaugurated by the Ministry of Health, Chairman of BRIN, and Head of BPOM, setting the tone for a comprehensive discussion on the future of healthcare in Indonesia. In his opening remarks, the Minister of Health emphasized Indonesia’s pressing need for health innovation, particularly in addressing the country’s high healthcare costs, which pose a significant burden on its citizens. To mitigate this challenge, the Minister extended an invitation to Chinese investors to bring new technologies that could enhance accessibility, affordability, and innovative solutions for Indonesia’s life expectancy age, which often face limited healthcare funding.

One of the keynote speakers, Ibu Rizka Andalucia, Director General for Pharmaceutical and Medical Devices at the Ministry of Health, expressed her hope that the summit would yield meaningful collaborations on high-tech, cost-efficient devices. She highlighted the Ministry’s strategic approach to supporting a conducive ecosystem for research and collaboration, which encompasses three critical aspects: regulation, innovation, and clinical. By fostering an environment that encourages innovation and investment, the Ministry aims to drive progress in Indonesia’s healthcare sector.

In line with this vision, the government has issued regulations to accelerate the use of domestic products, providing opportunities for local manufacturing investments to enter the Indonesian market. This move is expected to not only stimulate economic growth but also enhance the country’s self-sufficiency in meeting its healthcare needs. Additionally, the government has announced various incentives to support local industries, further solidifying its commitment to developing a robust healthcare ecosystem.

Throughout the summit, participants engaged in lively discussions, sharing insights and expertise on various topics, including investment opportunities in Indonesia’s healthcare sector, regional regulatory frameworks, and innovative partnership models. The event provided a valuable platform for stakeholders to forge new partnerships, explore business opportunities, and contribute to shaping the future of healthcare in Indonesia.

As the summit concluded, participants left with a renewed sense of purpose and optimism, inspired by the potential for growth and innovation in Indonesia’s healthcare sector. With its strategic location, growing economy, and commitment to healthcare reform, Indonesia is poised to become a key player in the region’s healthcare landscape.

Prodia the CRO will attend the upcoming DIA 2025

Posted on May 20, 2025May 20, 2025 by Superadmin CRO Prodia

Prodia the CRO looks forward to attending the upcoming DIA Global Annual Meeting 2025 that will take place in Washington DC from 15-19 June 2025.

The DIA 2025 Global Annual Meeting is hosted in Washington, DC. DIA 2025 will amplify different perspectives while highlighting expertise in life sciences and healthcare industries across the globe. The conference features a diverse range of sessions, workshops, and panel discussions, making it an essential event for anyone involved in the pharmaceutical and biotechnology sectors.

We also invite you to visit Indonesia Town Hall to explore more about the Indonesian Clinical Trials Landscape and Opportunities. During this session there’ll be a discussion about the recent transformations in Indonesian clinical research regulations and their impact on the country’s research environment; Recognize the opportunities and challenges for global pharmaceutical companies conducting clinical research in Indonesia under the new regulatory framework. On this event you’ll have a chance to directly discuss with the Head of Indonesia Regulatory, a representative from Clinical Research Unit, and Chair of Indonesian Association for the Study of Medicinals (IASMED).

Indonesia Town Hall will be held on Jun 18, 2025, at 1:45 PM – 2:45 PM in Walter E. Washington Convention Center 150AB.

Click this link to see the details Indonesia Town Hall and schedule https://www.diaglobal.org/en/flagship/dia-2025/program/schedule/agenda

The DIA 2025 Global Annual Meeting invites industry, regulators, governments, academics, innovators, and patients to network and problem-solve challenges facing the life sciences community.

Come meet our team and connect with us at DIA 2025!

Please contact [email protected] to book a meeting. (CDF)

IASMED Seminars 2025 “Moving Forward: Indonesian Clinical Trial”

Posted on January 24, 2025 by Superadmin CRO Prodia

The IASMED 2025 Scientific Seminar “Moving Forward: Indonesian Clinical Trial” was held on Saturday, January 18, 2025, by Indonesia’s clinical trial association, The Indonesian Association for The Study of Medicines (IASMED).

Prof. dr. Tarunan Ikrar, M.Biomed. PhD was speaking about Readiness of Clinical Trial Site on IASMED Scientific Seminar January 18th, 2025

This seminar is aimed to provide IASMED members to update information regarding clinical trial sites in order to improve the quality and quantity of clinical trials in Indonesia, especially multi-regional clinical trials (MRCT). There are two sessions on this scientific seminar. The first session consists of 4 speakers that are apt. Indri Rooslamiati, M.Sc as the Head of BB Binomika, Prof. dr. Taruna Ikrar, M.Biomed., Ph.D – Head of BPOM, Prof. Young Joo Par as Vice President DIA Korea, Singapore, and Southeast Asia and Dra. Endang W. Hoyaranda as the head of IASMED. The second session is a panel discussion with the clinical trial stakeholders. One of the main speaker is Prof. dr. Taruna Ikrar, M.Biomed., Ph.D – Head of BPOM. He said that BPOM will continue to supervise the clinical trial center’s infrastructure and personnel and keep fostering collaboration and integration among academia, business, and governance. There is also a networking session on this seminar where IASMED members can meet representatives from Clinical Research Unit of many hospitals and other clinical trials collaborators.

Panel Discussion Session that discuss about Clinical Research Unit (CRU) and the Future of Indonesia Clinical Trial on IASMED Scientific seminar that was held on January 18th, 2025.

In this event, also was attended bt clinical trial professionals such as Prof. Dr. Rianto Setiabudy, Prof. Arini Setiawati, and Prof. Young Joo Park, Vice President of the Drug Information Association (DIA) Korea, Singapore, and Southeast Asia, Indri Rooslamiati, M.Sc., Apt. Head of BB Binomika, CRUs, sponsors, global and local CROs.

In addition to the scientific agenda,during this eventalso celebrated the election of the IASMED chairs, including the new IASMED committee chairs and IASMED supervisory board chair. May IASMED continued success and contribute more to enhancing the quality and quantity of clinical trials in Indonesia.

Prodia the CRO, believes that this marked as an excellent time for clinical trials in Indonesia. Prodia the CRO is a Contract Research Organization (CRO) based in Indonesia which provides GCP-based Clinical Trial supports through our integrated and wide range of services. Prodia the CRO has accumulated many experiences providing services to local as well as multinational companies with commitment to reach quality through qualified and dedicated resources. It provides customers in GCP trials with competitive costs, firm timeliness, and high compliance to ICH-GCP guidelines(CDF).

IASMED Virtual Course and Workshop on Good Clinical Practice 20 – 21 September 2024

Posted on September 10, 2024 by Superadmin CRO Prodia

The Indonesian Association for The Study of Medicinals (IASMED) will hold the Virtual Course & Workshop on Applied Good Clinical Practice (GCP) on 20 – 21 September 2024. This training has been recognized by TransCelerate BioPharma.

The speakers are clinical trial experts & practitioners in Indonesia that will share useful information for conducting and evaluating clinical trials. Participant will be involved in interactive workshop and case-study application for Good Clinical Practice principle in clinical trial.

To participate on this event, please register at: https://bit.ly/GCPIASMED

“Happy Independence Day, Indonesia!”

Posted on August 16, 2024August 16, 2024 by Superadmin CRO Prodia

Today, 17^th of August, we pay tribute to the legacy of our forebears who fought for the freedom we cherish. Indonesia’s march towards independence stands as a testament to the fortitude and resilience of its citizens. As we commemorate our 79^th Independence Day, let us reflect on the sacrifices of our heroes and the enduring spirit of our people.

This day serves as a reminder of the power in our unity and the splendour in our diversity. Our national motto, “Bhinneka Tunggal Ika” – Unity in Diversity, embodies the vigour and richness of our multicultural legacy. This ethos of solidarity and tenacity also inspires Prodia the CRO, as we join hands to improve our capacity and capability for clinical trials in Indonesia. Let us strive to shape an Indonesia that fills us with pride, a place where every individual has the opportunity to realize their aspirations.

“May our country flourish and continue to make its mark on the world stage. Wishing everyone a joyous Independence Day and may the essence of Merdeka perpetually guide us. Let the flame of liberty illuminate our journey!” Prodia the CRO.

Happy Independence Day, Indonesia! Merdeka!

Prodia the CRO attend the 5th ARSPTN Annual Meeting

Posted on July 25, 2024July 25, 2024 by Superadmin CRO Prodia

Prodia CRO representative with Prof. dr. Nasronudin, Sp.PD-KPTI the chairman of ARSPTN

[Bandung, Indonesia] On 20 July 2024, Prodia the CRO attended the 5^th annual meeting of the Association of Public University Hospital / Asosiasi Rumah Sakit Perguruan Tinggi Negeri (ARSPTN) in Bandung.

The existence of public universities hospital began when the Ministry of Health issued temporary permits for seven dental and oral hospitals (RSGM) belonging to public universities (perguruan tinggi negeri) simultaneously on 27 June 2002. These seven dental and oral hospitals were belonging to University of North Sumatra, University of Indonesia, Padjadjaran University, Gadjah Mada University, Hasanuddin University, Airlangga University, and Jember University.

Meanwhile, general hospitals (RSU) that belong to the public universities began with the establishment of hospitals that belong to Gadjah Mada University and Hasanuddin University in 2010, followed by hospital that belong to Airlangga University in 2011. Other public university hospitals were established afterwards in many places according to the Ministry of Research, Technology and Higher Education (Kemenristekdikti) program at those time. In 2023, there were 39 public universities hospitals that consisted of 25 general hospitals and 14 Dental and Oral Hospitals. The dynamics in managing public universities hospitals creating a sense of togetherness which was later manifested in the establishment of ARSPTN on 28 October 2017 in Surabaya. To exchange ideas and experiences, ARSPTN routinely held an annual meeting. In 2024, the fifth ARSPTN annual meeting was held in Trans Luxury Hotel Bandung on 19-21 June 2024 and hosted by Padjajaran University Oral and Dental Hospitals. This meeting was attended by representatives from many public universities teaching hospital in Indonesia. The theme of this 5^th annual meeting is “Strengthening Hospital Competitiveness in the New Era Post the Implementation of Undang-undang No. 17 tahun 2023 regarding Health”

On the fifth ARSPTN Annual Meeting, two MURI (Indonesia World Records Museum) records were broken that are MURI World Records on Playing Angklung to accompany HIV song by the largest number of health care workers and MURI Indonesia Records: interprofessional education program with the largest number of students.

Prodia the CRO was one of the Sponsors for the ARSPTN 5^th annual meeting. During this meeting, Dr. apt. Ida Paulina Sormin, M.Si, as a Site Management Organization Manager (SMO) of Prodia the CRO, gave a short presentation about the Development of Clinical Research Unit (CRU) for improving Clinical Trials in Indonesia. During the event, Prodia the CRO was also inviting the public university hospitals to collaborate with SMO for Clinical Research Unit Development.